It's studied for mobilizing stored fat (lipolysis) and blocking new fat storage (lipogenesis) through adipose-tissue pathways, without engaging appetite or insulin signaling
[4] Other symptoms may include shortness of breath, feeling faint, a smooth red tongue, pale skin, chest pain, nausea and vomiting, loss of appetite, heartburn, numbness in the hands and feet, difficulty walking, memory loss, muscle weakness, poor reflexes, blurred vision, clumsiness, depression, and confusion
The rate of loss accelerates during the dose escalation phase and typically peaks around weeks 16-32 when you reach higher maintenance doses
Both peptides show systemic bioactivity but act most strongly at sites of injury or inflammation
B6 Supports development, alleviates nausea, and lowers risk of preeclampsia and birth defects